Skip to main content
Caplight Logo









ToxGenSolutions B.V.

ToxGenSolutions B.V.

Private
MaastrichtHealthcare & Life Scienceshttps://toxgensolutions.eu

Last Round

Accelerator

Jul 2, 2024

Company Overview

ToxGenSolutions B.V. is a biotechnology company that develops diagnostic tools and epigenetic biomarker fingerprints for the identification and classification of toxicants and the preclinical diagnosis of chronic pathologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

molecular diagnosticscontract research organizationCROnon-animal testingneurodegenerative diseasepreclinical safety assessmentepigenetic biomarkermicroRNA profilingbrain organoidin vitro screeningtoxicogenomicsdrug discoverynew approach methodologiesNAMsanimal-free testingearly disease detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ToxGenSolutions B.V. Comparables

Compare ToxGenSolutions B.V. with similar companies based on industry and business-model similarity.

No public comparables are available for ToxGenSolutions B.V.. Request access to learn about comparables coverage.

Request access

ToxGenSolutions B.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJul 2, 2024

ToxGenSolutions B.V. Investors

Notable investors and investment history

ToxGenSolutions B.V. investors
InvestorRounds
Gates VenturesAccelerator
StartUp HealthAccelerator
Alzheimer's Drug Discovery FoundationAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2024

    Secured funding from Gates Ventures and StartUp Health.

  • Jun 5, 2024

    Grew 60% QoQ from 5 to 8 employees.

ToxGenSolutions B.V. Filings

Explore SEC and related filing metadata, where available.

ToxGenSolutions B.V. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ToxGenSolutions B.V.'s valuation, stock price, and market status.

Is ToxGenSolutions B.V. a public or private company?

ToxGenSolutions B.V. is a private company.

What is the current stock price of ToxGenSolutions B.V.?

ToxGenSolutions B.V. is a private company with no public stock price. Caplight tracks ToxGenSolutions B.V.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is ToxGenSolutions B.V. worth (valuation)?

Valuation information for ToxGenSolutions B.V. is not publicly available.

Can I buy ToxGenSolutions B.V. stock?

ToxGenSolutions B.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ToxGenSolutions B.V.'s last funding round?

ToxGenSolutions B.V.'s most recent funding round was Accelerator on July 2, 2024.

Who are the main investors in ToxGenSolutions B.V.?

Key investors in ToxGenSolutions B.V. include Gates Ventures, StartUp Health, Alzheimer's Drug Discovery Foundation.

Will ToxGenSolutions B.V. IPO soon?

No public IPO plans have been announced for ToxGenSolutions B.V..

How can I track ToxGenSolutions B.V. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ToxGenSolutions B.V.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMaastricht
Year Founded2015
Last FundingJul 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?